This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Newsouth Innovations Pty Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Mark Duncan Perry Willcox: Innovator in Antimicrobial Compounds
Introduction
Mark Duncan Perry Willcox is an accomplished inventor based in Balmain, Australia. He has made significant contributions to the field of antimicrobial compounds, focusing on innovative solutions to combat bacterial infections and biofilm formation. His work is vital in addressing public health challenges related to bacterial resistance.
Latest Patents
Mark Willcox holds a patent for antimicrobial compounds, specifically related to compounds of Formula (I) and their salts. This patent highlights the antibacterial and anti-biofilm activities of these compounds. The application also discusses compositions that include these compounds and methods for treating or preventing bacterial infections, as well as inhibiting biofilm formation.
Career Highlights
Mark is associated with Newsouth Innovations Pty Limited, where he applies his expertise in developing novel antimicrobial solutions. His work has garnered attention for its potential impact on healthcare and infection control.
Collaborations
Mark collaborates with notable colleagues, including Shashidhar Nizalapur and Naresh Kumar. Their combined efforts contribute to advancing research in antimicrobial technologies.
Conclusion
Mark Duncan Perry Willcox is a key figure in the development of antimicrobial compounds, with a focus on innovative solutions to combat bacterial infections. His contributions are essential in the ongoing fight against antibiotic resistance and improving public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile